The Influence of Antibiotics on the Normal Flora

Infections in Medicine

Volumn 15, Issue SUPPL. A, 1998, Pages 15-22

  Peter Guggenbichler, J ^a   Kastner, U ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antibiotic resistance; Macrolides; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFALEXIN; CEFIXIME; CEFUROXIME AXETIL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BIOAVAILABILITY; CONFERENCE PAPER; DRUG HALF LIFE; HUMAN;

EID: 0031971477     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chopra I, Hodgson J, Metcalf D, et al: New approaches to the control of infections caused by antibiotic-resistant bacteria. JAMA 275:401-403,1996.
2. Barg N: New resistance mechanisms of common pathogens. Contemp Intern Med 7:6169,1995.
3. Jones RN: The emergent needs for basic research, education, and surveillance of anti-microbial resistance: The recommendations and implementation problems facing the report from ASM Task Force on Antibiotics Diagn Microbiol Infect Dis 25:153-161,1996.
4. Jones RN, Jacobs MR, Washington JA, et al: A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents: A 187 clinical laboratory center sample in the United States. Diagn Microbiol Infect Dis 27(3):75-83,1997.
5. Felmingham D: Antibiotic resistance: Do we need new therapeutic approaches? Chest 108:570-578,1995.
6. Lister PD: Multiply resistant Pnaimococais: Therapeutic problems in the management of serious infections. Eur J Clin Microbiol Infect Dis 14(suppl l):18-25,1995.
7. Retsema JA, Girard AE, Brennan LA: Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic , azithromycin. Eur J Clin Microbiol Infect Dis' 10:843-846,1991.
8. Goldman RC, Capobianco JO: Role of an I energy-dependent efflux pump in plasmid ' pNE 24-mediated resistance to 14- and 15- I membered macrolides in Staphyhcoccus epidermidis. Antimicrob Agents Chemother ' 34(10):1973-19SO, 1990. j
9. Bauernfeind A, Jungwirth R, Eberlein E: Vergleich der Pharmakodynamik von Clarithro- ' mycin und Azithromycin bei Erregern von Atemwegsinfektionen. Infection 23:316-321, 1995. '
10. Gotfried MH, Rodvold KA, Danziger LH: Intrapulmonary concentrations of clarithromycin and azithromycin at steady-state in normal healthy adults. Presented at 10th Mediterranean Congress of Chemotherapy. Antalya, Turkey, October 20-25,1996.
11. Piscitelli SC, Rodvold KA: Clarithromycin and azithromycin: New macrolide antibiotics. Clin Pharmacol 11:137-152,1992.
12. Jones RN: An appraisal of orally administered drugs used for respiratory tract infections. Diagn Microbiol Infect Dis 27:21-28,1997.